Skip To Main Content
N Creus Baró on Muck Rack

N Creus Baró

As seen in: European Journal of Hospital Pharmacy
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with N Creus

Contact N Creus, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

DI-093 Off-label drug use in onco-haematology setting

|
By C Codina Jané, N Creus Baró, A Manzaneque Gordon, C Chaguaceda Galisteo
| European Journal of Hospital Pharmacy Verified
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Open in Who Shared Issue with article?

CP-141 Eribulin use in metastatic breast cancer

|
By R Fernandez Fernandez, N Creus Baró, C Codina Jané
| European Journal of Hospital Pharmacy Verified
Background Eribulin has recently been indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimen for advanced disease. However, eribulin use in our hospital is still limited to patients who have previously received two treatment lines for metastatic disease, including taxanes and anthracyclines (as adjuvant or metastatic setting).
Open in Who Shared Issue with article?
See all 2 articles